re: 5.appointment to prepare for ind appl. in mid
http://stocknessmonster.com/news-item?S=EPT&E=ASX&N=217547
"Drug-development company EpiTan Limited (ASX:EPT) today announced that it had appointed former FDA dermatology specialist Dr Ella Toombs as a regulatory
advisory consultant.
Dr Toombs’ prime focus will be to assist EpiTan prepare its Investigational New Drug (IND) application for Melanotan, which will be submitted to the US Food & Drug Administration in mid-2004".
Info on EPT:
http://www.hotcopper.com.au/post_thread.asp?fid=1&tid=61463&sym=EPT#156349
Gerry
Readers, please do your own research and you decide if and when to buy, hold or sell any stocks.
5. data and comments. 5, page-66
-
- There are more pages in this discussion • 126 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CUV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$15.27 |
Change
-0.090(0.59%) |
Mkt cap ! $762.4M | |||
| Open | High | Low | Value | Volume |
| $15.30 | $15.55 | $15.13 | $318.0K | 20.83K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 58 | $15.25 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $15.28 | 8 | 2 |
View Market Depth
| Last trade - 12.13pm 18/07/2024 (20 minute delay) ? |
| CUV (ASX) Chart |